Mr. Yon is a transactional and licensing lawyer with extensive experience in funding and licensing technology for biotechnology and pharmaceutical companies. He has negotiated and closed more than 50 major (>$1 million) licensing, distribution and collaboration agreements with pharmaceutical, biotechnology, medical device and clean energy companies. He has represented major research institutes and educational institutions and has licensed technology from leading research universities.
Mr. Yon serves as outside General Counsel for several of his clients. He provides licensing, regulatory and compliance advice, antitrust analysis, contract review and business strategies advice to his clients.
Mr. Yon was Senior Vice President, General Counsel and Secretary at Coley Pharmaceutical Group from 2001 through 2008 where he was responsible for all legal and regulatory matters, including patent prosecution and litigation strategy. Coley completed the largest biotech IPO in 2005 ($120 million) and raised approximately $100 million in private round equity investments. Mr. Yon was the co-leader of the team which negotiated and completed the sale of Coley to Pfizer in 2008 for $250,000,000.